Hostname: page-component-745bb68f8f-v2bm5 Total loading time: 0 Render date: 2025-02-11T03:37:55.668Z Has data issue: false hasContentIssue false

Ethical Guidelines in Pandemic Influenza: Recommendations of the Ethics Subcommittee of the Advisory Committee of the Director, Centers for Disease Control and Prevention

Published online by Cambridge University Press:  08 April 2013

Rights & Permissions [Opens in a new window]

Abstract

Because of the importance of including ethical considerations in planning efforts for pandemic influenza, in February 2005 the Centers for Disease Control and Prevention requested that the Ethics Subcommittee of the Advisory Committee to the Director develop guidance that would serve as a foundation for decision making in preparing for and responding to pandemic influenza. Specifically, the ethics subcommittee was asked to make recommendations regarding ethical considerations relevant to decision making about vaccine and antiviral drug distribution prioritization and development of interventions that would limit individual freedom and create social distancing. The ethics subcommittee identified a number of general ethical considerations including identification of clear goals for pandemic planning, responsibility to maximize preparedness, transparency and public engagement, sound science, commitment to the global community, balancing individual liberty and community interests, diversity in ethical decision making, and commitment to justice. These general ethical considerations are applied to the issues of vaccine and antiviral drug distribution and use of community mitigation interventions. (Disaster Med Public Health Preparedness. 2009;3(Suppl 2):S185–S192)

Type
Special Focus
Copyright
Copyright © Society for Disaster Medicine and Public Health, Inc. 2009

The first human cases of a new and extremely severe avian influenza virus—the H5N1 strain—were detected in Hong Kong in 1997, when 18 cases (6 of which were fatal) were reported.1 As of March 2, 2009, 409 laboratory confirmed human cases of avian influenza A (H5N1) have been reported in 15 countries (mostly in Asia); of these cases, 256 have died.2 The H5N1 virus is of great concern due to the severity of the disease it produces and the high mortality rate (approximately 60%).

Public health officials have been studying past influenza pandemics to gain a better understanding of the potential impact of a pandemic and to obtain insight into pandemic preparedness and response.Reference Markel, Stern and Navarro3 The Department of Health and Human Services (HHS) has estimated that if a pandemic influenza virus with similar severity as the 1918 Spanish flu developed in the United States, then 1.9 million Americans could die and almost 10 million could be hospitalized.4

In addition to high levels of morbidity and mortality, an influenza pandemic could be accompanied by significant social disruption and economic impact. The number of people requiring medical intervention could overwhelm health care facilities, the supply of antiviral drugs may not be sufficient to address the demand, and delays and shortages in the availability of vaccines are expected. Potential public health interventions that target reducing the spread of the infection (eg, interventions such as isolation of ill individuals and quarantine for exposed people) would result in disruption of usual activities and essential services.

Preparing for and responding to pandemic influenza raises a number of ethical issues. Who should receive priority for limited resources? How should decisions be made that would limit an individual’s civil liberties? How and when will information be provided to the public? How will the needs of vulnerable populations be addressed? Increased attention has been focused on the need for pandemic influenza plans to address these ethical questions.Reference Gostin5Reference Wynia11 In addition, several international and state health organizations are developing ethical guidance for pandemic influenza.1215 Efforts have been made by DHHS to engage the public in a deliberative discussion about pandemic influenza preparedness goals and priorities. These public engagement projects have focused on challenging ethical issues such as prioritization of the distribution of pandemic influenza vaccine and use of liberty-limiting interventions to mitigate the spread of disease.16, 17

Because of the importance of including ethical considerations in planning efforts for pandemic influenza, in February 2005 the Centers for Disease Control and Prevention (CDC) requested that the Ethics Subcommittee of the Advisory Committee to the Director develop guidance that would serve as a foundation for decision making in preparing for and responding to pandemic influenza. This guidance, which follows below, was developed on behalf of the ethics subcommittee by the authors. Input on the guidance was provided by other members of the ethics subcommittee, the CDC Advisory Committee to the Director, the CDC Public Health Ethics Committee, and other CDC staff.

Planning efforts for pandemic influenza acknowledge uncertainty about timing, onset, and severity of the illness and the importance of planning for the full spectrum of possible pandemic severity. HHS guidance on community strategies for pandemic influenza mitigation introduced the concept of the Pandemic Severity Index for categorizing the severity of a pandemic.18 This index, based on the case fatality ratio, assists in predicting the impact of a pandemic and serves as a tool for matching community strategy recommendations to the severity of the pandemic. HHS’s recent guidance on allocating and targeting pandemic influenza vaccine also takes into account pandemic severity.19 Rather than exploring the possible range of pandemic severity, the discussion of the ethical considerations that follows is designed for a severe pandemic with high levels of morbidity and mortality and significant stress on critical infrastructure. Our focus on a severe pandemic and the resulting significant impact on social systems led us to emphasize the importance of prioritizing actions that will maintain the functioning of society.

The guidance below identifies primary ethical considerations and principles that may be used by those implementing pandemic influenza plans. The guidance does not attempt to provide specific directives or to assess state and local plans that have recently been developed. The document emphasizes a “procedural ethics” approach. Throughout the guidance concepts such as public engagement, transparency, and fair process are emphasized. Equally important is the establishment of oversight and appeals mechanisms to ensure fairness in decision making and to revise or correct approaches as new information becomes available. In developing this guidance, the ethics subcommittee recognized that there are some fundamental issues that need to be addressed to ensure that individual rights are protected and that vulnerable populations are not disadvantaged by pandemic preparedness efforts. Decisions regarding allocation of scarce resources should be guided by criteria that maximize fairness in the distribution process. Use of measures that place limitations on individual liberties should be implemented with care and be informed by the best available scientific evidence of their effectiveness. During a pandemic, difficult choices will need to be made. It is the intent of the guidance that follows to provide an ethical framework for guiding decision makers at all levels in preparing for and responding to pandemic influenza. The guidance includes several ethics terms and conceptual constructs (eg, “morally relevant distinction”) that some readers may find unfamiliar. For definitions of these terms and explanations of these constructs, the reader is referred to 2 recent publications.Reference Beauchamp and Childress20, Reference Coughlin and Beauchamp21

ETHICAL GUIDELINES IN PANDEMIC INFLUENZA

This document provides proposed ethical guidance for decision making in preparing for and responding to pandemic influenza. The document was developed in response to a request from CDC that the ethics subcommittee address ethical considerations in vaccine and antiviral drug distribution prioritization and in the development of interventions that would limit individual freedom and create social distancing. (In discourse on pandemic influenza, often referred to as nonpharmaceutical interventions, “social distancing” refers to methods for reducing frequency and closeness of contact between people to decrease the risk of transmission of disease. Examples of social distancing include cancellation of public events such as concerts, sports events, or movies; closure of office buildings, schools, and other public places; and restriction of access to public places such as shopping malls or other places where people gather.) As in many other areas of community or public decision making, ethical issues are frequently encountered in this decision making process. Although difficult decisions are made on a regular basis, the process for decision making, including the framework and reasoning that support ethical choice, may not be clearly articulated. We are acutely aware of the need to have ethical perspectives provide practical assistance and to have these proposed guidelines fully vetted by those involved in the pandemic influenza planning and response process. We offer the following document with both commitments in mind and attempt to articulate the boundaries and underlying ethical premises that can serve as a marker against which to test implementation decisions. In using these guidelines, decision makers at all levels—federal, local, state, tribal, and so forth—should continue to exercise their best judgment in particular situations.

General Ethical Considerations

Identification of clear overall goals for pandemic planning is essential to making difficult choices. Historically, the organizing principle for resource (antiviral and vaccine) distribution in interpandemic years has been the minimization of serious influenza-associated complications, including hospitalization and death. Individuals most at risk for experiencing the serious negative health consequences of hospitalization or death if infected are given priority in receiving influenza vaccinations. The recommendations of 2 federal advisory committees—the Advisory Committee on Immunization Practices (ACIP) and the National Vaccine Advisory Committee (NVAC)—reflect this principle. (The NVAC/ACIP recommendations for prioritization of pandemic influenza vaccine are described in the HHS Pandemic Influenza Plan available at http://www.hhs.gov/pandemicflu/plan/appendixd.html. Vaccine and antiviral manufacturers, medical and public health workers, and people at highest risk for influenza complication are identified as priority groups for receipt of pandemic influenza vaccine.)

However, in pandemic influenza management, a second principle—that of preserving the functioning of society—should receive greater priority in decision making than preventing serious complications. Those individuals who are essential to the provision of health care, public safety, and the functioning of key aspects of society should receive priority in the distribution of vaccine, antivirals, and other scarce resources. Engagement of diverse stakeholders will be essential in affirming this priority, determining who is considered key to the functioning of society, and establishing a distribution strategy that allows for decisions to be made when resources are limited. In any prioritization proposal, it must be clearly acknowledged that maintaining the functioning of society may result in a lack of resource availability to those at high risk for severe medical complications due to preexisting medical conditions or advanced age.

Affirming this second principle (preserving the functioning of society) raises important conceptual questions about who is valued and how particular services and functions are determined to be key. These questions are set in important historical and social contexts involving individuals’ ability to attain essential positions given societal barriers and obstacles. Discussion of these questions, although important in ordinary circumstances, takes on a lower priority when confronted with the urgent demands of preserving society.

There is a commitment to transparency throughout the pandemic influenza planning and response process. The reasoning behind choices made is fully articulated (in language appropriate to particular audiences) and the values and principles justifying those decisions are clearly identified and open for examination. This commitment to clarity and openness, which is based on a deep respect for all individuals and communities involved, exists in balance with the understanding that those with the authority and responsibility of making decisions must often make decisions in a timely manner.

Public engagement and involvement are essential to build public will and trust and should be evidenced throughout the planning and response process. The public is seen as a partner with other experts, with particular attention to vulnerable or historically marginalized members of society. Clear mechanisms must be created for public involvement in planning and for feedback throughout the process.

Public health officials have a responsibility to maximize preparedness to minimize the need to make allocation decisions later. (Examples of maximizing preparedness include shortening the time for virus recognition or vaccine production, increasing the capacity to produce vaccines or antivirals, and increasing the supplies of antivirals.) Proactive planning of response strategies for a pandemic, including the training of staff, is required. This necessarily entails consideration of the full context in which choices are made. Enhancing the available range of prophylaxis and treatment options should decrease the need to focus on scarcity of resources and allocation during a pandemic. Preparedness also includes determining and articulating what rules will govern public health decision making in advance of the time that decision making must commence. Although every specific choice or contingency cannot be foreseen, comprehensible foundational guidelines and procedural action plans provide coherence and direction and build trust.

Sound guidelines should be based on the best available scientific evidence. There is no need to establish rules for the equitable distribution of goods that will not work or to implement public health interventions that are ineffective. This is as equally true for vaccines and antivirals as it is for social distancing measures. Because the scientific basis for efficacy of particular interventions continues to be studied and models projecting the course of a pandemic are being investigated, sound scientific evidence for proposed interventions may not exist. The current knowledge basis should serve as a foundation for ethical guidelines and a commitment to ongoing scientific and ethical evaluation of interventions should be made.

Working with and learning from preparedness efforts globally is essential. The United States recognizes its membership in the global community. This recognition is not based simply on the potential for global involvement to benefit US citizens (an “instrumental” reason), but on a deep recognition of the common good and our interdependence globally. Mechanisms for global involvement and criteria for determining the scope of impact of US decisions should be explicit. (The common good refers to the interests of a group or collective that is defined by having in common certain attributes [eg, location in a geographically defined community, risk for a specific disease] that create a commonality of interests. Its use in this context reflects an understanding that, in the case of an influenza pandemic, all human beings are part of a single collective that has a common good.)

Balancing community interests and individual liberties: Pandemic influenza planning, like other public and community health activities, is a cooperative and shared responsibility that balances community and individual interests. During the course of a pandemic, the functioning of society may be threatened. Our moral tradition embodies an understanding that it may be ethically acceptable (or perhaps even ethically mandatory) to suspend some (but not all) ordinary moral rules in such circumstances. For example, limits on individual freedom or choice may be necessary to protect individuals as well as entire communities during pandemic influenza. Yet, individual liberty should be restricted with great care and only when alternative approaches to realizing the goal of weathering the pandemic are not likely to be effective. Suspensions of ordinary moral rules should be anticipated and the conditions calling for such suspensions should be specified.

Guiding principles in determining these restrictions include the following:

  • Adopting the least restrictive practices that will allow the common good to be protected

  • Ensuring that restrictions are necessary and proportional to the need for protection

  • Attempting to ensure that those affected by restrictions receive support from the community (eg, job security, financial support for individuals and their families, provision of food and other necessities to those who are isolated or placed under quarantine, protection against stigmatization or unwarranted disclosure of private information).

Diversity in ethical decision making: Given numerous historical examples of abuse of individuals, particularly those who are considered vulnerable, in the name of the public good (eg, involuntary sterilization of the mentally retarded, the US Public Health Service syphilis study at Tuskegee, the internment of Japanese-Americans during World War II), public health officials must adequately acknowledge and respond to strong currents of suspicion and distrust of the health care system. This acknowledgement is, of course, part of a much larger health care dialog. Addressing this distrust should be a strong and enduring commitment, and not viewed as merely instrumental to inducing individuals to comply with recommendations. Diverse public voices should be involved in determining the need for restrictions and in articulating the ethical justification for these restrictions.

Fair process approach: We recommend an approach to justice that focuses on the procedures to be followed with the hope that good procedures will lead to fair outcomes. Following are the elements of an ideal procedural justice approach:

  • Ensuring consistency in applying standards across people and time (treating like cases alike)

  • Identifying decision makers who are impartial and neutral

  • Ensuring that those affected by the decisions have a voice in decision making and agree in advance to the proposed process

  • Treating those affected with dignity and respect

  • Ensuring that decisions are adequately reasoned and based on accurate information

  • Providing communications and processes that are clear, transparent, and without hidden agendas

  • Including processes to revise or correct approaches to address new information, including a process for appeals and procedures that are sustainable and enforceable

The involvement of diverse voices in pandemic influenza planning and in creating a transparent procedure for decision making is essential. In addition to engaging citizens in general, this process would involve those who are primarily responsible for implementing the pandemic influenza plans (eg, direct health care providers who would be asked to commit to providing care even in the face of personal risk or the competing needs of their own families).

A balance between centralized, federal control and state and local community implementation of central guidelines must be effectively struck (see “Ethical Guidelines Regarding Social Distancing and Restrictions on Personal Freedom for Managing Pandemic Influenza” section for more discussion of the strong presumption in favor of centralized decision making during a pandemic). This process should be especially attentive to historically marginalized communities and those in which sensitivity to cultural, racial, religious, or other values must be incorporated.

Thoughtful preparation and attention to process will not provide guidance in all specific circumstances. The practice of attending to fair process may provide support for local decision makers addressing unanticipated questions. In addition, these decision makers must be authorized to use their best judgment in addressing and resolving particular issues.

Addressing Particular Ethical Issues in Pandemic Influenza Planning

Allocation of Resources

The distribution of goods should be guided by criteria specified well in advance of any need to apply them. As indicated earlier, the primary goals of the distribution system should be clearly specified. Further distribution criteria should be evaluated according to their ability to contribute to the realization of the primary goals. These further criteria should be directed at maximizing fairness (or equity) in the distribution process.

We have concluded that a classic utilitarian approach to defining priorities, “the greatest good for the greatest number,” is not a morally adequate platform for pandemic influenza planning. We recommend an approach to ethical justification that, like utilitarianism, evaluates the rightness or wrongness of actions or policies primarily by their consequences, but we further recommend that planning should take into account other checks (“side constraints”) grounded in the ethical principles of respect for people, nonmaleficence, and justice. For example, a classic utilitarian approach, which may accept imposing suffering on the few for the greater benefit of all, would be tempered by such principles as the following:

  • Refraining from harming or injuring individuals and communities

  • Ensuring equal opportunity to access resources for those within agreed upon priority groups

  • Respecting individual autonomy by, for example, employment of the least restrictive interventions that are likely to be effective

Distribution plans should further specify the following:

  • What scarce goods are involved in the distribution plan? The names of the individual vaccines or classes of goods (eg, antivirals for the purpose of treating or preventing influenza) should be communicated publicly. It would also help to specify what will not be covered by the distribution plan and why (eg, drugs that treat or prevent certain disorders or conditions that make one more susceptible to contracting influenza). Who (or what agency) will decide about prioritization and distribution? A mechanism for authoritative interpretations of the rules in the case of a dispute or an appeal is needed.

  • Who is eligible to be a recipient? (eg, will all individuals present in the local community be eligible, regardless of visitor status? Will the local community encourage travelers to return to home communities to receive the scarce resource? Will exceptions be made? If so, why?)

  • What morally relevant criteria will be used to assign higher or lower priorities to groups of individuals or individuals within the determined goal (preserving the functioning of society)? For example, are certain key services more essential than others? Within the organization or group of individuals who provide an essential service, are there justified criteria for determining a further order of priority (eg, those with more years of experience or those who have dealt with crises in the past)?

Some theoretical distribution criteria that would generally not be ethically supported in pandemic influenza planning include the following:

  • To each according to purchasing power

  • To each according to what he or she deserves

  • First come, first served. (Superficially, this may appear to be fair but, de facto, this puts certain groups—such as those who are less likely to be informed or those who have inadequate transportation—at a disadvantage.)

  • Criteria based on race, ethnicity, religious belief, gender, sexual orientation, or IQ, when used to make discriminations that are only invidious and not morally relevant

Under ordinary circumstances, the distribution criterion “to each according to his or her social worth” is not morally acceptable. In planning for a pandemic in which the primary objective is to preserve the function of society, however, it is necessary to identify certain individuals and groups of people as key to the preservation of society and to accord them a high priority for the distribution of certain goods such as vaccines and antiviral drugs. Identification of key individuals for this purpose must be recognized for what it is: It is a social worth criterion and its use is justified in these limited circumstances. Care must be taken to avoid extension of the evaluation of social worth to other attributes that are not morally relevant.

Among the goods that must be allocated is the time of health care professionals. It may be necessary to delegate the responsibility and authority to perform procedures and interventions customarily carried out by certain professionals to other less formally qualified individuals. For example, physicians may need to delegate duties to nurses, physicians’ trained assistants, and other personnel (eg, retired health care professionals) who may not be part of the customary health care team. Similarly, procedures customarily carried out by nurse practitioners and other health care professionals may also be delegated. Such delegations of authority and responsibility should be carefully planned and suitable training programs should be activated in advance of the pandemic.

Ethical Guidelines Regarding Social Distancing and Restrictions on Personal Freedom for Managing Pandemic Influenza

In the management of a pandemic, it will often be prudent to use procedures and interventions that will limit the freedom of movement of individuals or create conditions of social distancing. In general, the proposed use of such interventions and procedures should be in the form of recommendations for voluntary action. Requirements for mandatory liberty-limiting and social distancing interventions should be imposed only in cases in which voluntary actions seem unlikely to be effective. This point notwithstanding, the remainder of this section is concerned primarily with circumstances in which mandatory liberty-limiting and social distancing interventions are being considered.

As noted earlier, sound guidelines should be based on the best available scientific evidence. Ideally, the validity of liberty-limiting and social distancing interventions would be established in a manner similar to that used for pharmacological interventions, through carefully controlled research. In most cases this will not be possible, however, particularly in the circumstances of a pandemic. Indeed, in the course of a pandemic, it may be necessary to implement some interventions which have little or no scientific support. The model we recommend is that of evidence-informed decision making, a model that is somewhat less rigorous than evidence-based decision making but something that must suffice until more satisfactory validation becomes available.

Liberty-limiting and social distancing interventions include the following:

  • Isolation of individuals infected with or ill with influenza.

  • Quarantine of individuals thought to have already been exposed, including family members and others in close contact.

  • Closure of schools, cancellation of public events (eg, sports events, concerts), and closure of public venues such as shopping malls, restaurants, museums, and theaters, as mechanisms to decrease social contact that may lead to the spread of influenza.

  • Restriction of access to public venues deemed more essential, such as grocery stores, public transportation, and gasoline stations.

  • Provision of guidance on office practices and/or flexible work scheduling that decreases potential for exposure.

  • Limit travel within or between cities or local regions.

IS RESTRICTING PERSONAL FREEDOM IN MANAGING PANDEMIC INFLUENZA JUSTIFIED?

Implementing any of these interventions involves restricting personal freedoms that are strongly held and highly valued in US society. The ethical concept of individual autonomy, or the freedom to make one’s own decisions, is deeply embedded in US culture. Respect for individual autonomy is founded on the inherent dignity and worth of the individual and the understanding of each individual’s general right to noninterference. Therefore, justification for any restrictions on individual freedom must be carefully considered.

Legitimate restrictions on individual freedom may occur if, in exercising one’s freedom, one places others at risk. An individual does not have the right to injure another or to take someone’s property merely because she or he wishes to exercise her or his freedom. In addition, implicit in membership in society is an obligation to abide by certain ethical and legal constraints to enjoy the benefits of membership in that society (eg, security, health care, general welfare). These constraints actually provide the conditions under which personal freedom and flourishing are possible. Thus, restrictions essential to the common good, including the public health, of society may be imposed on each member of society. Even so, these restrictions on personal freedom must always be carefully considered and justified.

PROCEDURAL CONDITIONS IN RESTRICTING PERSONAL FREEDOM

We have set forth criteria for an acceptable system for allocation of resources, including some characteristics of satisfactory distribution plans and unacceptable distribution criteria. These allocation considerations are equally applicable to developing guidelines regarding restrictions on personal freedom and other nonpharmaceutical interventions for managing pandemic influenza.

The process for decision making about restrictions should be well thought out in advance. Both the decision makers and the criteria that will be used to determine when restrictions will be implemented should be specified. The group that specifies the decision makers and the criteria should be seen by all types of stakeholders as representative or otherwise acceptable. The group that is involved in implementing the policies, educating the public, and hearing objections should also be seen as representative or otherwise acceptable. A reasonably diverse infrastructure that includes voices across racial, cultural, community, provider, and recipient groups should be involved in planning, understanding the process, and conveying the process throughout the community. In pandemic influenza, centralization of decision making may be important in creating fair and equitable restrictions that will apply across communities. A process should be in place for objections to be heard, for restrictions to be appealed, and for new procedures to be considered before implementation.

As in other areas of pandemic influenza management, transparency about the process is essential and communication about restrictions should begin early in the planning process. The public should be clearly informed that restrictions on personal freedom are anticipated, that these limitations may be important to the individual’s own protection, and that they are also necessary to limit the spread of disease throughout the community. Communication should encourage individuals to partner with their communities and society at large in controlling influenza transmission. Information should be provided thoughtfully, balancing when information should be shared with protection of privacy and public trust.

In pandemic influenza, there is a strong justification for centralization of decision making. This is a departure from the customary mode of public health decision making, which occurs at the local, state, or tribal level by standards of their own choosing. General maxims and criteria for restrictions on personal freedom would be supported by equity and by the need to preserve the functioning of society across communities, including the tracking of disease. Local autonomy in decision making should be honored when there is no evidence to support a belief that centralization of decision making will contribute substantially to preservation of the functioning of society and when the easing of restrictions is proportional and reasonable in particular communities (eg, uniform duration of school closing may not be reasonable in communities where the influenza wave has already ended). Local decision makers should be prepared to make their reasoning transparent in these situations; they must be authorized to use their best judgment and supported in their efforts to do so.

WHEN ARE RESTRICTIONS ON PERSONAL FREEDOM ETHICALLY JUSTIFIED?

In enacting any measure in which personal freedom is limited, the least restrictive, effective measure should be taken. Enactment of these measures should be based on the best available scientific evidence that:

  • The liberty-limiting measure will achieve its intended goal.

  • The limitation is proportional and no less restrictive measure is likely to be as effective. An exception to this criterion may be justified if the less restrictive measure would be unduly burdensome (eg, either too expensive or the agency responsible for implementation lacks the resources or expertise to implement).

  • Failure to implement the measure is likely to result in grave harm to the functioning of society or to the well-being of the public. For example, if quarantine is enacted, then the duration of the quarantine should be clearly informed by transmission characteristics and should be as short as is medically justifiable. Home quarantine should be honored when reasonable and desired, and monitoring/surveillance should be as nonintrusive as is reasonable. We should continually be asking what justifies one further restrictive step.

Restrictions on personal freedom should be equitably applied. It should be exceedingly clear why particular individuals or communities are being restricted and that the criteria that justify a restriction would be equally applied to any and all individuals meeting the same criteria. Care must be taken to avoid stigmatization of individuals or groups. In addition, a process for questioning, appealing, and revising liberty-limiting measures should be in place and accessible when the level of urgency during a crisis makes this realistic.

When closure of public venues is being considered, determination must be made of which public venues are more essential in maintaining the functioning of society and may need to remain open with some constraints on level of access (eg, grocery stores may need to remain open with some new mechanism for distribution that safeguards both fair access and decreased potential dissemination of disease, such as maximum order amounts or a delivery service). Other examples of possible essential services are public transportation systems and gasoline stations.

Agencies responsible for imposing restrictions such as quarantine, isolation, or other limitations must take into consideration the fact that the affected population, their family members, and other dependents will require adequate access to food, water, and other essential services. Such agencies should attempt to secure access to these requirements for the affected parties. Similarly, they should attempt to provide protection of the restricted individuals’ jobs and their ability to meet economic obligations such as mortgage or rent payments, utility bills, and so forth. (It is beyond the scope of our mandate to specify which agencies should have decision-making authority regarding liberty-restricting measures. We do not mean to suggest that such agencies are responsible for the provision of necessary goods and services. Rather, they should attempt to ensure that some agency stands prepared to provide such goods and services. In some cases, they may be unable to do so. This should not be seen as an absolute barrier to implementation of the liberty-restricting measure. Instead, this should be treated as a serious cost when undergoing the obligatory cost–benefit analysis to decide whether a liberty-restricting measure is justified.)

There should be no unwarranted invasions of privacy and the mechanisms for maintaining confidentiality of private information should be secure. When information sharing is important to protecting the public health, measures that safeguard personal, private information should be in place and support should be given to ill individuals, family members, and others potentially stigmatized by real or potential illness.

Throughout this process, respect for individual freedom must continue to be an extremely high priority. Translating this respect also involves serious acknowledgment of a past history of neglect and abuse of personal freedom in multiple US health care programs, all with the best of public health intentions. This history is not taken lightly; the ability to restrict individual freedom to protect the common good requires careful reflection and examination throughout the management of an influenza pandemic.

CONCLUSIONS

This document seeks to provide a framework of ethical considerations to guide decision makers at all levels in preparing for and responding to pandemic influenza. As such, these guidelines are not narrowly prescriptive, but do recognize the need of decision makers in particular communities or regions to transform this guidance into specific decisions. Ethical decision making assumes that such judgments will be based on current scientific knowledge, that effectiveness of interventions is carefully assessed, and that transparency of the process is evident. As specific decisions in particular communities are considered, processes should be in place for identifying which ethical issues were addressed, how guidelines were used, how decisions affected the community, and what lessons can be shared with other decision makers. In this way, these guidelines will continue to be an interactive, working document.

The purpose of this document is to provide ethical guidance relating to vaccine and antiviral drug distribution prioritization and use of liberty-limiting interventions. Although the issue of the duty of health care professionals to provide care during a pandemic is outside the scope of this document, the ethics subcommittee believes that this issue is of central importance in pandemic planning and response. An equally relevant issue, but also beyond the scope of this document, is the importance of providing legal protections for health care providers who, during a declared public health emergency, may be asked to perform services outside their usual realm of responsibilities or to administer interventions that are not yet scientifically validated. Optimal pandemic influenza preparedness will require that both of these issues be explored further in collaboration with health care providers and other stakeholders.

Ethics Subcommittee Members Involved in Developing the Recommendations

John Arras, University of Virginia

Georges Benjamin, American Public Health Association

Vanessa Northington Gamble, The George Washington University

Thomas Hooyman, Regis University

Bruce Jennings, Center for Humans and Nature

Mary desVignes-Kendrick, University of Texas Health Science Center at Houston

Barbara Koenig, Mayo College of Medicine

Kathy Kinlaw, Emory University

Robert Levine, Yale University

Ruth Macklin, Albert Einstein College of Medicine

James Thomas, University of North Carolina

Authors' Disclosures

The authors report no conflicts of interest.

References

REFERENCES

1.World Health Organization. Avian Influenza (“Bird Flu”) Fact Sheet. http://www.who.int/mediacentre/factsheets/avian_influenza/en/index.html#current. Accessed October 9, 2007.Google Scholar
2.World Health Organization. Cumulative Number of Confirmed Human Cases of Avian Influenza A/(H5N1) Reported to WHO. http://www.who.int/csr/disease/avian_influenza/country/en. Accessed March 11, 2009.Google Scholar
3.Markel, H, Stern, AM, Navarro, JA, et alNonpharmaceutical influenza mitigation strategies, US communities, 1919–1920 pandemic. Emerg Infect Dis. 2006;12:19611964.Google Scholar
4.Department of Health and Human Services. National Strategy for Pandemic Influenza. November 1, 2005. http://www.whitehouse.gov/homeland/nspi.pdf. Accessed October 9, 2007.Google Scholar
5.Gostin, LO.Pandemic influenza: public health preparedness for the next global health emergency. J Law Med Ethics. 2004;32:565573.Google Scholar
6.Childress, JF.Just care: rationing in a public health crisis. Update. 2005;20:17.Google Scholar
7.Kass, NE.An ethics framework for public health and avian influenza pandemic preparedness. Yale J Biol Med. 2005;78:239254.Google Scholar
8.Kotalik, J.Preparing for an influenza pandemic: ethical issues. Bioethics. 2005;19:422431.Google Scholar
9.Gostin, L.Public health strategies for pandemic influenza: ethics and the law. JAMA. 2006;295:17001704.CrossRefGoogle ScholarPubMed
10.Gostin, LO.Medical countermeasures for pandemic influenza: ethics and the law. JAMA. 2006;295:554556.CrossRefGoogle ScholarPubMed
11.Wynia, MK.Ethics and public health emergencies: rationing vaccines. Am J Bioeth. 2006;6:47.CrossRefGoogle Scholar
12.World Health Organization. Addressing Ethical Issues in Pandemic Influenza Planning. http://www.who.int/ethics/influenza_project/en/index.html. Accessed October 9, 2007.Google Scholar
13.University of Toronto Joint Centre for Bioethics Pandemic Influenza Working Group. Stand on Guard for Thee: Ethical Considerations in Preparedness Planning for Pandemic Influenza. November 2005. http://www.jointcentreforbioethics.ca/publications/documents/stand_on_guard.pdf. Accessed March 11, 2009.Google Scholar
14.Minnesota Center for Health Care Ethics. Allocating Pandemic Influenza Vaccines in Minnesota: Recommendations of the Pandemic Influenza Ethics Work Group, September 2006. http://www.stolaf.edu/mnethx/PanFluReport.pdf. Accessed October 9, 2007.Google Scholar
15.New Mexico Department of Health. Pandemic Influenza Emergency Response, Ethics Guidance and Matrix. http://www.health.state.nm.us/ohem/documents/appendix%2012%20ethics%20Web%20Ready.pdf. Accessed October 9, 2007.Google Scholar
16.Keystone Center. Citizen Voices on Pandemic Flu Choices: A Report of the Public Engagement Pilot Project on Pandemic Influenza, December 2005. http://www.keystone.org/spp/health-pandemic.html#community. Accessed November 29, 2007.Google Scholar
17.Keystone Center. The Public Engagement Project on Community Control Measures for Pandemic Influenza: Findings and Recommendations From Citizen and Stakeholder Deliberation Days, May 2007. http://www.keystone.org/spp/health-pandemic.html#community. Accessed November 29, 2007.Google Scholar
18.US Department of Health and Human Services. Interim Pre-pandemic Planning Guidance: Community Strategy for Pandemic Influenza Mitigation in the United States—Early, Targeted, Layers Use of Nonpharmaceutical Interventions, February 2007. http://www.pandemicflu.gov/plan/community/commitigation.html. Accessed December 14, 2007.Google Scholar
19.US Department of Health and Human Services. Guidance on Allocating and Targeting Pandemic Influenza Vaccine. http://www.pandemicflu.gov/vaccine/allocationguidance.pdf. Accessed November 14, 2008.Google Scholar
20.Beauchamp, TL, Childress, JF.Principles of Biomedical Ethics, 6th ed. New York: Oxford University Press; 2008.Google Scholar
21.Coughlin, SS, Beauchamp, TL.Ethics in Epidemiology, 2nd ed. New York: Oxford University Press; 2008.Google Scholar